home *** CD-ROM | disk | FTP | other *** search
- Newsgroups: misc.invest
- Path: sparky!uunet!paladin.american.edu!howland.reston.ans.net!usc!sdd.hp.com!ux1.cso.uiuc.edu!news.cso.uiuc.edu!usenet
- From: jhsu@dcl-nxt54.cso.uiuc.edu (Jason Hsu)
- Subject: Re: Any thoughts on Bristol-Myers?
- References: <29951@oasys.dt.navy.mil>
- Message-ID: <C16823.6nw@news.cso.uiuc.edu>
- Sender: usenet@news.cso.uiuc.edu (Net Noise owner)
- Organization: University of Illinois at Urbana
- Distribution: usa
- Date: Wed, 20 Jan 1993 21:08:26 GMT
- Lines: 17
-
- In article <29951@oasys.dt.navy.mil> wade@oasys.dt.navy.mil (Michael Wade)
- writes:
- >
- > Our investment club is considering purchasing Bristol-Myers Squibb
- (BMY).
- > However, this stock has recently been pummeled by the hysteria over
- > Clinton's proposed health care reform. The stock is about 64 now.
-
- I believe BMY is overvalued (though not a short sale candidate).
- According to Value Line, the book value of BMY is only about $16/share (I
- forget the exact figure). At $64, the price/book value ratio is a
- broiling-hot 4, compared with the S&P's historical average of 1.8. I
- believe that a bear market, earnings growth that slows down, or earnings
- reports that fall a few pennies short of expectations will cause BMY to
- crash. However, if BMY crashes and has a price/book ratio of 2/3 or less
- (bitter cold), the stock would be a screaming buy because of the earnings
- and dividend growth.
-